Singapore-based health technology startup Zeya Health has raised USD 575,000 in pre-seed funding from Antler and a group of strategic angel investors to expand its AI-native platform for healthcare providers across the Asia-Pacific region.
The funding follows rapid adoption of Zeya’s platform, driven by rising patient volumes and growing administrative pressure on clinics that are struggling to scale with limited staff. Asia-Pacific’s healthcare market is projected to approach USD 5 trillion by 2030, but the region continues to face a severe shortage of healthcare professionals, creating a widening gap between demand for care and operational capacity.
Zeya Health positions itself as an AI-powered front desk for clinics, integrating directly into existing electronic medical records and communication platforms such as WhatsApp. The system automates appointment reminders, follow-ups, rescheduling and patient engagement without requiring clinics to change their existing software or workflows. Providers can be onboarded in under 48 hours, as the system scans current workflows and deploys AI-driven processes without new logins, manual rule-setting or staff retraining.
Since launching in August, the company has reported more than 20-fold growth in the number of clinics using its platform, with consistent month-on-month expansion. As adoption accelerates, Zeya is working with larger healthcare groups to standardise workflows, reduce manual administrative work and improve patient engagement across multiple locations. Singapore-based healthcare provider AcuMed is currently assessing the platform for a multi-clinic pilot.
Antler, which made Zeya’s first institutional investment after its residency programme, increased its backing as the company demonstrated demand-led growth and execution.
Zeya was founded by Agastya Samat and Pasindu Wijesena, who built the platform in response to firsthand experience with inefficiencies in healthcare systems. Samat previously worked on large-scale digital health deployments with the UK’s National Health Service and a major Middle Eastern insurer, while Wijesena led large engineering teams and built AI-driven products before the generative AI boom.
The fresh capital will be used to accelerate product development and expand deployments among private healthcare providers in Singapore and other Asia-Pacific markets. The company is also hiring engineers and clinical deployment specialists to support its growth.
Zeya Health currently serves providers in physiotherapy, primary care, paediatrics, surgical clinics and aesthetic outpatient services, with plans to expand into additional care models and regional markets in 2026. The company aims to become a core AI infrastructure layer that allows healthcare organisations to scale patient care while reducing operational strain.
Also Read